Loading...
Several studies in patients with diabetes and known cardiovascular disease (CVD) have suggested that lower is better for both LDL cholesterol (LDL-C) levels and systolic blood pressure (SBP). In an NIH-funded study, researchers assessed whether lower-risk people with diabetes and without known heart disease also benefit from lower targets.
A total of 499 adult Native Americans with type 2 diabetes but without known CVD were randomized to aggressive (LDL-C level, ≤70 mg/dL; SBP, ≤115 mm Hg) or standard treatment targets (LDL-C level, ≤100 mg/dL; SBP, 130 mm Hg), using stepwise drug treatment approaches and lifestyle modifications. Carotid intima–media thickness (IMT) and left ventricular function were assessed at baseline, 18 months, and 36 m…